Sign In
Buy TOMDF
$0.000001
+0 (+0%)
At Close: Jun 02, 2026
Todos Med (OTCMKTS:TOMDF) and Aclarion (NASDAQ:ACON) Head-To-Head Survey
01:15am, Saturday, 28'th Mar 2026
Aclarion (NASDAQ: ACON - Get Free Report) and Todos Med (OTCMKTS:TOMDF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the stre
Reviewing Todos Med (OTCMKTS:TOMDF) & Auna (NYSE:AUNA)
02:52am, Friday, 27'th Mar 2026
Auna (NYSE: AUNA - Get Free Report) and Todos Med (OTCMKTS:TOMDF - Get Free Report) are both medical companies, but which is the better stock? We will compare the two companies based on the strength o
Financial Analysis: GeneDx (NASDAQ:WGS) & Todos Med (OTCMKTS:TOMDF)
02:35am, Sunday, 28'th Dec 2025
Todos Med (OTCMKTS:TOMDF - Get Free Report) and GeneDx (NASDAQ: WGS - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the
Todos Medical Announces Insolvency Proceedings in Israel
05:28pm, Friday, 22'nd Dec 2023
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, Israel, Dec. 22, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), an innovative healthcare solutions company, today announce
Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
11:01am, Tuesday, 26'th Sep 2023
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Sept. 26, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire - Todos Medical, Ltd. (OTCQB: TOMDF), an innovative healthcare solutions company, today pro
Todos Announces Notice of Allowance From USPTO for Patent Application Covering Use of Compositions In Tollovid™ and Tollovir™ Ingredients
08:19am, Wednesday, 30'th Aug 2023
Claims covering inhibition of 3CL protease, inflammation and autophagy underscore Dr. Dorit Arad's lifelong work NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Aug. 30, 2023 (GLOBE NEWSWIRE) -- vi
Todos Medical enters LOI for Provista Diagnostics to license key PCR-based sepsis diagnostic test
09:54am, Tuesday, 28'th Mar 2023
Todos Medical Ltd. (OTCQB:TOMDF) announced it has entered into a letter of intent (LOI) with Acumen Diagnostics of Singapore for its CLIA/CAP-certified clinical testing lab Provista Diagnostics to li
Todos Medical expresses support for Long COVID sufferers, plans to study Tollovid's usefulness in patients
03:42pm, Wednesday, 15'th Mar 2023
Todos Medical Ltd CEO Gerald Commissiong has shared the company's aim to open a prospective study to confirm the usefulness of its dietary supplement Tollovid in cases of Long COVID. The CEO discussed
Todos Medical updates investors on its lab Provista Diagnostics, subsidiary 3CL Pharma, and Todos Botanicals automated retail rollout
11:36am, Thursday, 23'rd Feb 2023
Todos Medical Ltd has provided investors with an update on its corporate activities, including its moves to capitalize on the renewed interest in PCR testing to identify patients infected with COVID,
Todos Medical says Provista Diagnostics lab kicks off validation plan for PCR-based bird flu test for humans
10:16am, Tuesday, 14'th Feb 2023
Todos Medical Ltd. (OTCQB:TOMDF) announced that its CLIA/CAP-certified Provista Diagnostics laboratory has initiated a validation plan for polymerase chain reaction (PCR)-based Avian Influenza A (H5N
Todos Medical to Present at the RHK 2022 Disruptive Growth Conference
10:10am, Tuesday, 06'th Dec 2022
New York, NY, and Tel Aviv, ISRAEL, Dec. 06, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire -- Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company
Todos Medical signs agreement to sell supplements via Affy Services' Smart Automated Retail Network
10:53am, Wednesday, 16'th Nov 2022
Todos Medical Ltd (OTCQB:TOMDF) said it has entered into a five-year agreement with Smart Automated Retail Network (SARN) to supply immune support supplements on a worldwide basis. Smart Automated Re
Todos Medical finds major 3Q revenue bump from COVID-19 testing services
11:38am, Tuesday, 15'th Nov 2022
Todos Medical Ltd reported third-quarter financial results that showed a surge in revenue and narrowing operating loss. The company posted revenue of $1.9 million in the three months ended September
Todos Medical to Host Third Quarter 2022 Earnings and Business Update Conference Call on November 15, 2022
06:26pm, Monday, 14'th Nov 2022
NEW YORK, NY, AND TEL AVIV, ISRAEL, Nov. 14, 2022 (GLOBE NEWSWIRE) -- via NewMediaWire – Todos Medical, Ltd. (OTCQB: TOMDF), a comprehensive medical diagnostics and related solutions company, today
Todos Medical clinical laboratory Provista Diagnostics submits emergency use application for its PCR monkeypox test
09:31am, Friday, 14'th Oct 2022
Todos Medical Ltd announced that its clinical laboratory Provista Diagnostics Inc has filed an Emergency Use Authorization (EUA) application with the US Food & Drug Administration for its PCR monkeypo
